Advertisement
Advertisement
CGC
Canopy Growth Corporation Common Shares
0.47
USDSponsored
-0.03
-5.42%
Nov 19, 15:59 UTC -5
Closed
After-Market
0.47
-0.01
-1.96%
Canopy Growth Corporation Common Shares (CGC) Earnings
CGC Earnings Reports
Positive Surprise Ratio
CGC beat 17 of 44 last estimates.
39%
Next Report
Date of Next Report
Feb 04, 2027
Estimate for Q3 27 (Revenue/ EPS)
$91.07M
/-$0.05
Implied change from Q2 27 (Revenue/ EPS)
+11.91%
/-50.00%
Implied change from Q3 26 (Revenue/ EPS)
+22.17%
/-72.22%
Canopy Growth Corporation Common Shares earnings per share and revenue
On Nov 06, 2026, CGC reported earnings of -0.10 USD per share (EPS) for Q2 27, missing the estimate of -0.03 USD, resulting in a -182.49% surprise. Revenue reached 81.37 million, compared to an expected 83.73 million, with a -2.81% difference. The market reacted with a -3.58% price change (close before vs. close after earnings).
Looking ahead to Q3 27, -- analysts forecast an EPS of -0.05 USD, with revenue projected to reach 91.07 million USD, implying an decrease of -50.00% EPS, and increase of 11.91% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Canopy Growth Corporation Common Shares's earnings and revenue for the latest quarter Q2 2027?
For Q2 2027, Canopy Growth Corporation Common Shares reported EPS of -$0.10, missing estimates by -182.49%, and revenue of $81.37M, -2.81% below expectations.
How did the market react to Canopy Growth Corporation Common Shares's Q2 2027 earnings?
The stock price moved down -3.58%, changed from $0.68 before the earnings release to $0.65 the day after.
When is Canopy Growth Corporation Common Shares expected to report next?
The next earning report is scheduled for Feb 04, 2027.
What are the forecasts for Canopy Growth Corporation Common Shares's next earnings report?
Based on --
analysts, Canopy Growth Corporation Common Shares is expected to report EPS of -$0.05 and revenue of $91.07M for Q3 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.